New cell therapy aims to speed up immune defense after cancer transplant
NCT ID NCT04707300
Summary
This early-stage study is testing a new cell injection called HTLP. The goal is to see if it can safely help the immune system rebuild itself faster in adults with blood cancers who receive a cord blood transplant. Faster immune recovery could lower the risk of serious infections after the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hematology department / Necker Children's Hospital
RECRUITINGParis, Île-de-France Region, 75015, France
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Saint Louis
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IUCT Oncopole Toulouse
RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Gustave Roussy
NOT_YET_RECRUITINGVillejuif, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service d'Hématologie et thérapie cellulaire / CHU of Bordeaux
RECRUITINGPessac, 33604, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.